Últimas noticias sobre Innate Pharma (NASDAQ:IPHA) Bolsa

INNATE PHARMA SA-SPONS ADR

Innate Pharma

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ALUR

ASST

AVBP

CNOB

DWTX

HSTM

IPHA

LGTY

MDXG

The Marygold Companies, Inc. Common Stock

MGLD

MULN

ONCO

PXLW

RMBI

TVGN

VINC

Explora los movimientos más destacados del pre-mercado, incluyendo el aumento del 23% en Logility y más sorpresas.

Acciones de Logility Supply Chain (LGTY) suben un 23%; 20 acciones que se mueven en el premercado de EE.UU.

Innate Pharma S.A. - American Depositary Shares

Innate Pharma SA

Navigator Holdings Ltd. (described herein as "Navigator Gas" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVGS#NYSE">NVGS</a>), the owner and operator of the world's largest fleet of handysize liquefied gas carriers, announces today that that the Company has been added to the broad-market Russell 3000 Index (the "Russell 3000") and the small-cap Russell 2000 Index (the "Russell 2000"), effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution.

NVGS

Navigator Gas Joins The Russell 3000 And Russell 2000 Indexes

WIIM

TRUG

TruGolf shares are trading higher after the company announced the launch of its LaunchBox launch monitor.

Nukkleus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUKK#NASDAQ">NUKK</a>), a company pursuing a highly disciplined global M&amp;A strategy in the Aerospace &amp; Defense (A&amp;D) industry, today announced that it was added to the Russell Microcap Index, effective after the US market opens on June 30, 2025, as part of the 2025 Russell indexes reconstitution.
In December 2024, the Company announced its plan to acquire a 51% controlling interest in Star 26 Capital Inc., which holds 100% of B. Rimon Agencies Ltd., an Israeli corporation that supplies defense related products including energy generators for Israeli's "Iron Dome" launchers. Closing is subject to the satisfaction of closing conditions, including shareholder vote.
The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Wednesday, April 30th, ranking them by total market capitalization. Membership in the Russell Microcap&#xAE; Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes.

NUKK

Nukkleus Added To Russell Microcap Index

KINS

Kingstone Added To Russell 3000 Index, With Automatic Inclusion In Russell 2000 Index, Effective June 30, 2025, As Part Of 2025 Russell Indexes Reconstitution

MGNI

Magnite shares are trading higher after Rosenblatt raised its price target on the stock from $18 to $39.

Sports

General

TruGolf Announces Launch Of Its LaunchBox Launch Monitor

GMS shares are trading higher after the company announced it will be acquired by a Home Depot subsidiary for $5.5 billion.

ESP Agreement to Facilitate&nbsp;the Deployment&nbsp;of UOTTA Battery-Swapping Stations and Sales of Four-Wheeled and Two-Wheeled Battery-Swapping Vehicles
SHANGHAI, June 30, 2025 /PRNewswire/ -- U Power Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) (the "Company" or "U Power"), a provider of comprehensive electric vehicle ("EV") battery-swapping solutions with a vision of becoming a smart energy grid solutions provider, today announced the signing of its first agreement with an Electric Service Provider (the "ESP") in Macau, aiming to facilitate the deployment and operation of U Power's UOTTA battery-swapping stations and cabinets, as well as the sale of compatible electric vehicles (EVs).
Pursuant to the agreement, the local ESP will be responsible for the installation and maintenance of U Power's UOTTA smart battery-swapping stations and cabinets in Macau. In addition, leveraging its existing partnership with UNEX EV B.V. (a Netherlands-based new energy and technology company which cooperates with OEM partners to design intelligent battery-swapping vehicles), U Power will work with the ESP to facilitate the sale and provide after-sale maintenance of compatible battery-swapping vehicles including four-wheeled passenger and commercial vehicles, and two-wheeled electric motorcycles, in the Macau market.

UCAR

U Power Signs Agreement With Electric Service Provider In Macau To Facilitate Deployment, Operation Of UOTTA Battery-Swapping Stations And Cabinets, As Well As Sale Of Compatible EVs

<a href="https://www.bloomberg.com/news/articles/2025-06-30/amazon-lost-right-to-sell-nintendo-switch-2-amid-sales-dispute" title="https://www.bloomberg.com/news/articles/2025-06-30/amazon-lost-right-to-sell-nintendo-switch-2-amid-sales-dispute">https://www.bloomberg.com/news/articles/2025-06-30/amazon-lost-right-to-sell-nintendo-switch-2-amid-sales-dispute</a>

AMZN

NTDOY

Bloomberg Reported Earlier, Amazon Lost Right To Sell Nintendo Switch 2 After Disagreement Over Unauthorized Sales

A highly reputable national and multinational customer base across eight market segments reinforces the quality of 5E's boric acid and reflects changing global supply-demand dynamics
HESPERIA, CA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / June 30, 2025 / 5E Advanced Materials, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEAM#NASDAQ">FEAM</a>)(ASX:5EA), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas (Fort Cady) Complex, announced today that 14 customers have successfully qualified 5E's boric-acid product. Additional customers have requested product or are in advanced phases of the testing process.
Customers that have qualified our product represent a diverse group of industries and market segments such as specialty glass, textile fiberglass, ceramics, insulation, agriculture, defense and chemicals. Testing programs to date have included laboratory evaluation, field trials, and truckload-scale shipments. This progress supports the Company's strategy to build a multi-market customer base across multiple high value sectors.

FEAM

5E Advanced Materials Announces That 14 Customers Have Qualified 5E's Boric-Acid Product; Additional Customers Have Requested Product Or Are In Advanced Phases Of The Testing Process.

PLTR

Palantir Technologies and Accenture shares are trading higher after the companies announced a partnership to collaborate on incorporating AI into federal agency workflows.

Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent Sensing
Achieves Strategic Inflection Point in 1H 2025 with Partnerships and Operational Breakthroughs
SAN DIEGO, CALIFORNIA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / June 30, 2025 / Ainos, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMD#NASDAQ">AIMD</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIMDW#NASDAQ">AIMDW</a>) ("Ainos" or the "Company") today announced the completion of a 1-for-5 stock consolidation, effective at the opening of trading on June 30, 2025. The move strengthens the Company's capital structure, aligns with Nasdaq listing requirements, and positions Ainos to scale global commercial operations across its AI Nose platforms.

AIMD

AIMDW

Ainos Completes 1-For-5 Stock Consolidation; Partners With ASE To Scale AI Nose Deployment

Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLR#NASDAQ">ALLR</a>), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a differentiated, dual PARP and WNT pathway inhibitor—as a personalized cancer treatment using its proprietary, drug-specific Drug Response Predictor (DRP&#xAE;) patient selection technology—today announced that IP Australia, the Australian Government agency that administers intellectual property rights in the country, has formally accepted the Company's patent application for its DRP&#xAE; companion diagnostic specific to stenoparib.
The acceptance covers 40 claims and marks a key step in Allarity's global strategy to protect the potential international commercialization of its proprietary DRP&#xAE; platform alongside the clinical development of stenoparib. The granted patent will be officially advertised in the Australian Official Journal of Patents on June 26, 2025, followed by a three-month opposition period. If unopposed, the patent is expected to be granted within 20 working days thereafter.

Biotech

Global

ALLR

Allarity Therapeutics' Patent Application For DRP Companion Diagnostic For Stenoparib Accepted By IP Australia

JOBY

Joby Completes Series Of Flights In dubai

Regulated entities can streamline stablecoin operations - permissioned or permissionless - using ALT5 Sigma's Crypto-as-a-Service platform, fully compatible with proprietary and third-party assets.
LAS VEGAS, NV / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / June 30, 2025 / ALT5 Sigma Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTS#NASDAQ">ALTS</a>)(FRA:5AR1), a leading provider of Crypto-as-a-Service infrastructure, has launched a comprehensive stablecoin management solution for U.S. institutions. Designed for regulated entities, the platform enables seamless integration, utilization, and oversight of stablecoins-regardless of the issuing entity or blockchain protocol. Whether managing proprietary tokens or leveraging market leaders, institutions can operationalize, monitor, and scale stablecoin use through ALT5 Sigma's infrastructure. Integration with existing workflows and systems is supported via robust APIs.

ALTS

ALT5 Sigma Launches Stablecoin Management Platform For U.S. Institutions, Enabling Seamless Integration Across Blockchains And Issuers

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) and Accenture Federal Services, a unit of Accenture Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>), have formed a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/b46164859/palantir-and-accenture-federal-services-join-forces-to-help-federal-government-agencies-reinvent-o/" rel="noreferrer noopener">strategic partnership</a> to provide cutting-edge artificial intelligence capabilities to U.S. federal agencies.
Under the agreement, Accenture Federal becomes a preferred implementation partner for Palantir&#8217;s platforms, focusing on enhancing mission-critical workflows and strengthening government operations through AI.
The collaboration will initially roll out three specialized offerings: &#8220;Enterprise-to-Edge Data Fusion,&#8221; which modernizes legacy systems to deliver real-time data to frontline operations; &#8220;Predictive Supply Chain Orchestration,&#8221; a tool to optimize and automate logistics across agencies; and &#8220;Operationalizing Financial Intelligence,&#8221; a solution designed to improve fiscal oversight by integrating budget data across systems.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46059174/accentures-raised-outlook-fails-to-ease-fiscal-2026-softness-worries-analyst" rel="noreferrer noopener">Accenture&#8217;s Raised Outlook Fails To Ease Fiscal 2026 Softness Worries: Analyst</a>
Accenture Federal will train and certify 1,000 members of its Data &amp; AI team on Palantir&#8217;s Foundry and AI Platform to support these efforts, building a delivery force capable of executing scalable, AI-enabled solutions across government functions.
Dr. Alex Karp, Palantir&#8217;s CEO, described Accenture as a &#8220;natural partner,&#8221; noting both firms share a commitment to delivering measurable impact. Julie Sweet, Chair and CEO of Accenture, emphasized how the partnership combines commercial innovation with federal expertise to modernize public services.
Mike Galagher, Palantir&#8217;s defense lead, framed the initiative as essential to national security, enabling smarter decisions on the battlefield.
Ron Ash, CEO of Accenture Federal Services, called the partnership a transformational step for government agencies seeking faster, more informed decision-making. &#8220;This is a game changer for our federal customers,&#8221; he said, pointing to the value of embedding AI into everyday agency operations.
Related ETFs: Global X Artificial Intelligence &amp; Technology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>), iShares U.S. Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYW#NYSE">IYW</a>).
Price Action: ACN shares gained 1.15% at $298.85, and PLTR was up 4.76% at $136.96 premarket on Monday&#8217;s last check.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/46161429/canada-rescinds-digital-services-tax-after-trump-calls-it-a-blatant-attack-on-america" target="_blank" rel="noreferrer noopener">Canada Rescinds Digital Services Tax After Trump Calls It A &#8216;Blatant Attack&#8217; On America</a></li>
</ul>
Image via Shutterstock

Tech

iShares Dow Jones US Technology Sector Index Fund

Palantir, Accenture Partner To Infuse AI Into Federal Agency Workflows

IMNN

IMUNON Submits Plan To Nasdaq To Regain Compliance with Minimum Bid Price Requirement

Agreement with Beijing Tongchuang Technology Development Co., Ltd. strengthens regional momentum through purchase, service, and licensing of flagship products
LAS VEGAS, June 30, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=tW_2zKoMPl4BWuM8L1BcEyj_jlqmqVW1MpAdGRQAlmZLUDV9b1egs8l78NifrUwOeWL6-u1mz_WBbHXQJIcZCuLer6wbhqv2UefGj1nva38=">Richtech Robotics Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RR#NASDAQ">RR</a>) ("Richtech Robotics" or the "Company"), a Nevada-based provider of AI-driven service robots, today announced the signing of a multi-million-dollar sales agreement with Beijing Tongchuang Technology Development Co., Ltd. by its Chinese joint venture, Boyu Artificial Intelligence Technology Co., Ltd.
The agreement, valued at over $4 million, includes the purchase, service, and software licensing of products from three of Richtech's key product lines: ADAM, Scorpion, and Titan. The deal expands the company's footprint in China and opens the door for additional potential opportunities across the Asian market. The agreement is expected to increase the company's fourth quarter revenue as well as to drive recurring revenue moving forward.

Contracts

Richtech Robotics Signs $4M Sales And Licensing Agreement In China To Expand Presence And Boost Q4 Revenue Through Flagship AI Robot Products

CDTX

Cidara Therapeutics Announces Addition To Russell 2000 And Russell 3000 Indexes

Eve Air Mobility ("Eve") (NYSE:<a href="https://www.benzinga.com/stock/EVEX#NYSE">EVEX</a>, EVEXW))&nbsp;has signed a Letter of Intent (LOI) with Aerosolutions, which is developing an innovative eVTOL operator called Aeros Electric Airlines, and Bluenest by Globalvia, Globalvia's Advanced Air Mobility infrastructure developer and vertiport operator, for the sale of up to 50 electric vertical take-off and landing (eVTOL) aircraft and access to Eve's comprehensive TechCare services—an all-in-one portfolio of services designed to streamline eVTOL operations, maintenance, and customer support. The agreement marks a significant step toward developing a robust Advanced Air Mobility (AAM) ecosystem in Costa Rica.

EVEX

Eve Air Mobility Signs LOI With Aerosolutions, And Bluenest By Globalvia For Sale Of Up To 50 eVTOL Aircraft And Access To Eve's Comprehensive TechCare Services

Press Releases

Innate Pharma announces conference call and webcast for Q1 2025 business update

Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025

Innate Pharma Reports First Quarter 2025 Business Update and Financial Results

Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress

Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting

Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides

Outcome of Innate Pharma's 2025 Annual General Meeting

Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences

Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress

Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences

Comments

Innate Pharma

Noticias

Últimas noticias sobre Innate Pharma (NASDAQ:IPHA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL